$1,000-per-pill drug overtaken by pricier successor

WASHINGTON (AP) ” The $1,000 pill for a liver-wasting viral infection that made headlines last year is no longer the favorite of patients and doctors in the U.S.The new leading pill for hepatitis C is more expensive, and the number…